Christopher P Alderman

1.1k total citations
65 papers, 720 citations indexed

About

Christopher P Alderman is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Christopher P Alderman has authored 65 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 12 papers in Geriatrics and Gerontology and 10 papers in Molecular Biology. Recurrent topics in Christopher P Alderman's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Schizophrenia research and treatment (8 papers) and Electroconvulsive Therapy Studies (6 papers). Christopher P Alderman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Schizophrenia research and treatment (8 papers) and Electroconvulsive Therapy Studies (6 papers). Christopher P Alderman collaborates with scholars based in Australia, United States and Indonesia. Christopher P Alderman's co-authors include Christopher J. Farmer, Yixin Yang, David I. Ben-Tovim, John T. Condon, Peter Allcroft, Peter Frith, Janet K. Sluggett, Linda McCarthy, J. Simon Bell and Markus G. Gebauer and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The British Journal of Psychiatry.

In The Last Decade

Christopher P Alderman

61 papers receiving 688 citations

Peers

Christopher P Alderman

IMMUN

PMH

EPIDE

Dean G. Haxby United States

Emmanuelle Bondon‐Guitton France

Victoria Zarotsky United States

Chung‐Hsuen Wu United States

P.H.M. van der Kuy Netherlands

Yolande Hanssens Qatar

Christopher S. Conner United States

C Aguirre Spain

Bradley R. Williams United States

Bruno Michel France

Dean G. Haxby United States

Christopher P Alderman

130 ×0.8

40 ×0.4

IMMUN

139 ×1.3

PMH

91 ×0.9

37 ×0.5

EPIDE

Citations per year, relative to Christopher P Alderman Christopher P Alderman (= 1×) peers Dean G. Haxby

Countries citing papers authored by Christopher P Alderman

Since Specialization

Citations

This map shows the geographic impact of Christopher P Alderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P Alderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P Alderman more than expected).

Fields of papers citing papers by Christopher P Alderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P Alderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P Alderman. The network helps show where Christopher P Alderman may publish in the future.

Co-authorship network of co-authors of Christopher P Alderman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P Alderman. A scholar is included among the top collaborators of Christopher P Alderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P Alderman. Christopher P Alderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Shasha, Xueni Li, Christopher P Alderman, et al.. (2025). Cryo-EM structures reveal the PP2A–B55α and Eya3 interaction that can be disrupted by a peptide inhibitor. Journal of Biological Chemistry. 301(7). 110287–110287. 1 indexed citations

Rahmadi, Mahardian, et al.. (2022). Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia. Pharmacy Practice. 20(4). 1–11. 2 indexed citations

Suharjono, Suharjono, et al.. (2019). In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 1 indexed citations

Suharjono, Suharjono, et al.. (2019). Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 5 indexed citations

Riemondy, Kent, Monica Ransom, Christopher P Alderman, et al.. (2018). Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries. Nucleic Acids Research. 47(4). e20–e20. 14 indexed citations

Chen, Esa Y. H., Janet K. Sluggett, Jenni Ilomäki, et al.. (2018). Development and validation of the Medication Regimen Simplification Guide for Residential Aged CarE (MRS GRACE). Clinical Interventions in Aging. Volume 13. 975–986. 29 indexed citations

Kowalski, S., et al.. (2017). Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation. International Journal of Clinical Pharmacy. 39(4). 867–873. 25 indexed citations

Alderman, Christopher P, et al.. (2016). MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene. Tumor Biology. 37(10). 13941–13950. 31 indexed citations

Sluggett, Janet K., et al.. (2016). Prevalence of multiple antipsychotic use and associated adverse effects in Australians with mental illness. International Journal of Evidence-Based Healthcare. 14(3). 104–112. 15 indexed citations

10.

Alderman, Christopher P, et al.. (2012). Survey of Australian Inpatients on Vaccination Status and Perceptions of Influenza Vaccination. The Consultant Pharmacist. 27(8). 553–563. 3 indexed citations

11.

Alderman, Christopher P. (2004). Developments in Psychiatry—2004. Journal of Pharmacy Practice and Research. 34(2). 149–151.

12.

Alderman, Christopher P, et al.. (2004). Mirtazapine‐Associated Rapid Weight Gain and Decreased Physical Activity. Journal of Pharmacy Practice and Research. 34(4). 308–309. 1 indexed citations

13.

Alderman, Christopher P. (2002). Syndrome of Inappropriate Antidiuretic Hormone Secretion Secondary to Venlafaxine. Journal of Pharmacy Practice and Research. 32(1). 35–36. 4 indexed citations

14.

Alderman, Christopher P, et al.. (2000). Nitrous Oxide Abuse in a Community Setting: Case Report. The Australian Journal of Hospital Pharmacy. 30(3). 109–110. 4 indexed citations

15.

Alderman, Christopher P. (1999). Creating the Future of Clinical Pharmacy in Australia. The Australian Journal of Hospital Pharmacy. 29(1). 28–30. 1 indexed citations

16.

Wiese, Michael D. & Christopher P Alderman. (1999). Unexpected Orthostatic Hypotension with Venlafaxine. The Australian Journal of Hospital Pharmacy. 29(4). 215–216. 2 indexed citations

17.

Alderman, Christopher P. (1998). Medication Alert Cards to Minimise Antidepressant Drug Interactions. The Australian Journal of Hospital Pharmacy. 28(4). 259–260. 1 indexed citations

18.

Galbraith, Kirsten, et al.. (1998). Australian Perspectives on the BPS Examinations. The Australian Journal of Hospital Pharmacy. 28(5). 334–342. 4 indexed citations

19.

Alderman, Christopher P. (1998). Perhexiline‐Paroxetine Drug Interaction. The Australian Journal of Hospital Pharmacy. 28(4). 254–255. 4 indexed citations

20.

Alderman, Christopher P, et al.. (1997). A Two‐Year Review of Risperidone Usage on an Acute‐Care, Adult Psychiatric Unit. The Australian Journal of Hospital Pharmacy. 27(1). 33–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact